
Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Global Forecast 2024-2030
Description
Intranasal Drug & Vaccine Delivery Market by Product (Liquid Delivery Device, Powder Delivery Device, Pressurized Metered Dose Inhaler), Dosage (Multi-Dose, Unit-Dose), Application, Distribution Channel - Global Forecast 2024-2030
The Intranasal Drug & Vaccine Delivery Market size was estimated at USD 51.89 billion in 2023 and expected to reach USD 55.88 billion in 2024, at a CAGR 8.17% to reach USD 89.93 billion by 2030.
Global Intranasal Drug & Vaccine Delivery Market
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Intranasal Drug & Vaccine Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intranasal Drug & Vaccine Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Intranasal Drug & Vaccine Delivery Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AstraZeneca PLC, Bausch Health Companies Inc., Baxter International, Inc., Becton, Dickinson, and Company, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Marina Biotech, Inc., Merck & Co., Inc., Neurelis Inc., Novartis AG, OptiNose, Inc., Pfizer Inc., Teleflex Incorporated, and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Intranasal Drug & Vaccine Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product
Liquid Delivery Device
Powder Delivery Device
Pressurized Metered Dose Inhaler
Dosage
Multi-Dose
Unit-Dose
Application
Neurological Disorders
Pain Management
Respiratory Disorders
Vaccination
Distribution Channel
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Intranasal Drug & Vaccine Delivery Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intranasal Drug & Vaccine Delivery Market?
3. What are the technology trends and regulatory frameworks in the Intranasal Drug & Vaccine Delivery Market?
4. What is the market share of the leading vendors in the Intranasal Drug & Vaccine Delivery Market?
5. Which modes and strategic moves are suitable for entering the Intranasal Drug & Vaccine Delivery Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
188 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Intranasal Drug & Vaccine Delivery Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of respiratory and neurological diseases
- 5.1.1.2. Expansion of supply chain networks and commercialization
- 5.1.1.3. Rise in number of prescriptions for non-invasive drug delivery routes
- 5.1.2. Restraints
- 5.1.2.1. Side effects associated with the use of nasal routes
- 5.1.3. Opportunities
- 5.1.3.1. Improving healthcare infrastructure and advanced treatment availability in developing economies
- 5.1.3.2. Technological advancements related to nasal drug delivery systems
- 5.1.4. Challenges
- 5.1.4.1. Development challenges such as requirements of large dose of vaccine and administration difficulties through the nasal route
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Intranasal Drug & Vaccine Delivery Market, by Product
- 6.1. Introduction
- 6.2. Liquid Delivery Device
- 6.3. Powder Delivery Device
- 6.4. Pressurized Metered Dose Inhaler
- 7. Intranasal Drug & Vaccine Delivery Market, by Dosage
- 7.1. Introduction
- 7.2. Multi-Dose
- 7.3. Unit-Dose
- 8. Intranasal Drug & Vaccine Delivery Market, by Application
- 8.1. Introduction
- 8.2. Neurological Disorders
- 8.3. Pain Management
- 8.4. Respiratory Disorders
- 8.5. Vaccination
- 9. Intranasal Drug & Vaccine Delivery Market, by Distribution Channel
- 9.1. Introduction
- 9.2. Hospital Pharmacies
- 9.3. Online Pharmacies
- 9.4. Retail Pharmacies
- 10. Americas Intranasal Drug & Vaccine Delivery Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Intranasal Drug & Vaccine Delivery Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.
- 10. South Korea
- 11.
- 11. Taiwan
- 11.
- 12. Thailand
- 11.
- 13. Vietnam
- 12. Europe, Middle East & Africa Intranasal Drug & Vaccine Delivery Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.
- 10. Nigeria
- 12.
- 11. Norway
- 12.
- 12. Poland
- 12.
- 13. Qatar
- 12.
- 14. Russia
- 12.
- 15. Saudi Arabia
- 12.
- 16. South Africa
- 12.
- 17. Spain
- 12.
- 18. Sweden
- 12.
- 19. Switzerland
- 12.
- 20. Turkey
- 12.
- 21. United Arab Emirates
- 12.
- 22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. 3M Company
- 14.1.2. AstraZeneca PLC
- 14.1.3. Bausch Health Companies Inc.
- 14.1.4. Baxter International, Inc.
- 14.1.5. Becton, Dickinson, and Company
- 14.1.6. GlaxoSmithKline PLC
- 14.1.7. Johnson & Johnson Services, Inc.
- 14.1.8. Marina Biotech, Inc.
- 14.1.9. Merck & Co., Inc.
- 14.1.
- 10. Neurelis Inc.
- 14.1.
- 11. Novartis AG
- 14.1.
- 12. OptiNose, Inc.
- 14.1.
- 13. Pfizer Inc.
- 14.1.
- 14. Teleflex Incorporated
- 14.1.
- 15. Teva Pharmaceutical Industries Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. INTRANASAL DRUG & VACCINE DELIVERY MARKET RESEARCH PROCESS
- FIGURE 2. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2023 VS 2030
- FIGURE 3. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. INTRANASAL DRUG & VACCINE DELIVERY MARKET DYNAMICS
- FIGURE 7. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2030 (%)
- FIGURE 10. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DOSAGE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
- FIGURE 14. INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INTRANASAL DRUG & VACCINE DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. INTRANASAL DRUG & VACCINE DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. INTRANASAL DRUG & VACCINE DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.